Journals / Fırat Tıp Dergisi / 2006 / Cilt: 11 - Sayı: 1

Apoptosis in ophthalmology

Oftalmolojide apopitoz

Pages
6–11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, to understand mechanisms that control apoptosis will allow benefits for therapy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Apoptosis is the genetically regulated form of programmed cell death that permits the safe disposal of cells when they are damaged and fulfilled their intended biological function.
📊
Key Findings & Data:Apoptosis is regulated by some oncogenes like p53 and Bcl-2.
💡
Conclusion & Impact:Thus, to understand mechanisms that control apoptosis will allow benefits for therapy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Keratokonus · Oftalmoloji · Retina hastalıkları

Abstract

Apoptosis is the genetically regulated form of programmed cell death that permits the safe disposal of cells when they are damaged and fulfilled their intended biological function. Apoptosis starts with death signals coming from outside or inside of the cell and continue with to activate the mechanisms of apoptosis via cell death receptor or mitocondrial pathways. During apoptosis a group proteases are activated which cause DNA fragmentation, cytoplasmic shrinkage and membrane blebbing. Apoptotic cells divide into apoptotic bodies and these apoptotic bodies are then removed from tissue by phagocytes and adjacent cells. Apoptosis is regulated by some oncogenes like p53 and Bcl-2. In ophthalmology, apoptosis plays role in pathogenesis of diseases like retinoblastoma, glaucoma, retinal degenerations, retinal detachment, keratoconus and some eye disorders. Thus, to understand mechanisms that control apoptosis will allow benefits for therapy

Özet

Apopitoz organizmada görevini tamamlamış ya da hasara uğramış hücrelerin çevre hücrelere zarar vermeden ortadan kaldırılmasını sağlayan, genetik olarak kontrol edilen programlanmış bir hücre ölümüdür. Apopitozda hücre içi veya dışı kaynaklı ölüm sinyalleri ve hücre ölüm reseptörü veya mitokondri yoluyla apopitotik mekanizma aktive olur ve sonuçta DNA kırılması meydana gelir. Apopitotik hücreler apopitotik cisimlere ayrılarak çevre hücreler tarafından fagosite edilirler. Apopitoz embriyogenez ve doku hemostazı gibi fizyolojik durumlarda veya iskemi, toksisite ve neoplazik değişiklikler sırasında ortaya çıkar ve p53, Bcl-2 gibi bazı onkogenler tarafından regüle edilir. Apopitoz retinoblastom, glokom, katarakt, retina dekolmanı, keratokonus ve bazı göz hastalıklarının patogenezinde rol oynadığından apopitozu kontrol eden mekanizmaların anlaşılması tedavi çabalarına katkıda bulunacaktır.

🔖

Cite This Article

TURGUT, B., DEMİR, T., ÇELİKER, Ü. (2006). Apoptosis in ophthalmology. Fırat Tıp Dergisi, Cilt: 11 - Sayı: 1, 6–11. https://ajindex.com/articles/223794

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Kinloch RA, Treherme JM, Furness LM. The pharmacology of apoptosis. Trends Pharmol Sci 1999; 20: 35-42
  2. Wilson SE. Stimulus-specific and cell type-specific cascades: emerging principles relating to control of apoptosis in th eye. Exp Eye Res 1999; 69: 255-266
  3. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res 1999; 18: 39-57
  4. Kerr JFR, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257
  5. Wyllie AH, Duvall H. Cell death. In: McGee JOD, Iseacson PG, Wright M, eds. Oxford Textbook of Pathology, vol 1. USA, Oxford University Pres 1992: 141-147
  6. Bosman FT, Visser BC, Ooveren JV. Apoptosis: Pathophysiology of programmed cell death. Path Res Pract 1996; 192: 676-683
  7. Mountz JD, Zhou T. Apoptosis and autoimmunity. In: Kopman WJ, ed. A Textbook of Rheumatology: Artritis and allied conditions. Lippincott-Williams&Wilkins 2001
  8. Pole RJ, Qi BQ, Beasley SW. Patterns of apoptosis during degeneration of the pronephros and mesonephros. J Urol 2002; 167: 269-271
  9. Staunton MJ, Gaffney G. Apoptosis. Basic concepts and potential significance in human cancer. Arch Pathol Lab Med 1998; 122: 310-319
  10. Carson DA, Rbiero JM. Apoptosis and disease. The Lancet 1993; 341: 1251-1254
  11. Melino G, Annicchiarico-Petruzzelli M, Piedda L. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994; 14: 6584-6596
  12. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501
  13. Sung CH, Schneider BG, Agarwal N, Papermaster DS, Nathans J. Functional heterogenicity of mutant rhodopsins responsible for autosomal dominant retinitis pimentosa. Proc Natl Acad Sci USA 1991; 88: 8840-8844
  14. Mosinger JL, Price MT, Bai HY, Yiao H, Wozniuk DF, Olney JW. Blockage of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vitro adult mammalian retina. Exp Neurol 1991; 113: 10-17
  15. Jones BA, Gores GJ. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas and intestine. Am J Physiol 1997; 273
  16. Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 2002; 109: 437-442
  17. Gastman BR. Apoptosis and its clinical impact. Head Neck 2001; 23: 409-425
  18. Gobe G, Zh